| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 2.836 | 66.321 | 47.830 | 7.780 | 8.273 | 8.248 | 7.659 |
| Total Income - EUR | - | - | - | 7.010 | 66.321 | 47.845 | 7.780 | 8.274 | 8.248 | 7.660 |
| Total Expenses - EUR | - | - | - | 4.157 | 17.668 | 14.100 | 597 | 600 | 8.196 | 4.001 |
| Gross Profit/Loss - EUR | - | - | - | 2.853 | 48.653 | 33.744 | 7.183 | 7.674 | 52 | 3.659 |
| Net Profit/Loss - EUR | - | - | - | 2.666 | 47.989 | 33.311 | 6.954 | 7.487 | -30 | 2.901 |
| Employees | - | - | - | 0 | 2 | 2 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Liovixrar S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 8.505 | 7.835 | 7.092 | 6.547 | 6.275 | 5.965 | 5.642 |
| Current Assets | - | - | - | 5.863 | 55.097 | 39.082 | 12.734 | 16.317 | 6.980 | 9.725 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 38 | 5.317 | 1 | 2 | 9 | 8 | 69 |
| Cash | - | - | - | 5.826 | 49.781 | 39.081 | 12.732 | 16.308 | 6.972 | 9.656 |
| Shareholders Funds | - | - | - | 13.659 | 58.770 | 45.683 | 19.231 | 20.897 | 12.247 | 15.080 |
| Social Capital | - | - | - | 952 | 934 | 916 | 896 | 898 | 896 | 891 |
| Debts | - | - | - | 709 | 4.163 | 491 | 50 | 1.695 | 697 | 287 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Liovixrar S.r.l.